Masters of Longevity - The Pulse

  1. THE LIVE Barcelona 2026 (Barcelona, Spain)26. OCT 2026 - 28. OCT 2026THE LIVE Barcelona 2026Media PartnerSummit - Barcelona, Spain★
  2. CEE Longevity Summit & Retreat 2026 (Samorin, Slovakia)29. OCT 2026 - 31. OCT 2026CEE Longevity Summit & Retreat 2026Retreat - Samorin, Slovakia
  3. Parkhotel Longevity Retreat — October 2026 (Bad Bayersoien, Germany)31. OCT 2026 - 8. NOV 2026Parkhotel Longevity Retreat — October 2026Retreat - Bad Bayersoien, Germany
  4. Biology of Aging Symposium V 2026: The Possibilities of Aging and Health (Montreal, Canada)1. NOV 2026 - 3. NOV 2026Biology of Aging Symposium V 2026: The Possibilities of Aging and HealthConference - Montreal, Canada
  5. Atlas Cove Longevity Residency — November 2026 (Setúbal, Portugal)1. NOV 2026 - 6. NOV 2026Atlas Cove Longevity Residency — November 2026Retreat - Setúbal, Portugal
Longevity Docs News23 Oct 2026
Epigenetic clocks predict mortality in 380,705 adults, meta-analysis preprint finds (Longevity Docs News)

Epigenetic clocks predict mortality in 380,705 adults, meta-analysis preprint finds

A preprint linked faster GrimAge ageing to higher mortality across 125 observational studies.

Key takeaways
  • The meta-analysis pooled 125 observational studies involving 380,705 adults.
  • The results are in a preprint and are not peer reviewed.
  • The observed associations are not evidence that ageing clocks cause death.
Nature - Biotechnology23 Oct 2026
Elizabeth Holmes film enthralls — but her legacy haunts science (Nature - Biotechnology)

Elizabeth Holmes film enthralls — but her legacy haunts science

Researchers report the Theranos scandal reduced trust in diagnostics and affects current blood-testing efforts.

Key takeaways
  • Researchers reported a lasting loss of diagnostic trust after Theranos.
  • Finger-prick tests are still limited by sampling and sensitivity.
  • Developers emphasised transparency and rigorous evidence over big promises.
Nature - Main23 Oct 2026
Moderna mRNA vaccine almost halves the risk of skin cancer returning (Nature - Main)

Moderna mRNA vaccine almost halves the risk of skin cancer returning

A phase III trial found intismeran with pembrolizumab reduced melanoma recurrence or death by 42%.

Key takeaways
  • The trial enrolled 1,137 people with stage IIIB–IV melanoma.
  • Individual vaccines were designed by sequencing each patient's tumour.
  • The overall survival outcomes remain uncertain pending longer follow-up.